Concerning cell cultures for biocompatibility-testing: Monitoring by DNA-fingerprinting

被引:0
|
作者
Falkner, E [1 ]
Frick, W [1 ]
Kapeller, B [1 ]
Eberl, H [1 ]
Macfelda, K [1 ]
Losert, UM [1 ]
机构
[1] Univ Vienna, Inst Biomed Forsch, AKH, A-1090 Vienna, Austria
来源
关键词
3R; cell culture; animal cells; DNA-Fingerprinting; biocompatibility;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Cell cultures are innovative tools for e.g. biocompatibility testing of biomaterials in vitro. In our studies we used fibroblast, endothelial cell and chondrocyte cultures of human origin and of the test animal species most common for this purpose in vivo. Verification of the identity of these cells is obligatory for reproducibility of the tests and Valid interpretation of the results. Cultured cells have to be checked for identity, contaminations of various origins and also for genomic mutations occuring during prolonged cultivation in vitro or due to exposition to biomaterials. Furthermore, the risk of genetic cross-contamination with other cells increases with the number of cell cultures passaged parallel in the same laboratory. Therefore, we generated reference fingerprints of the cultures in Varying passages for comparative monitoring of cells purposed for in vitro tests. Minisatelite DNA polymorhism resulting in reproducible individual DNA fingerprints is very discriminatory and can be used for cell culture monitoring. The patterns are stable over several passages, although sudden changes did happen in two cases, i.e. loss/gain of bands or changes in band-intensity, indicating massive genomic mutations of the cultures in vitro. Influences of biomaterials on the prints could not be detected. Several tasks can be followed at the same time: detection of contaminant cells, identification of these cells of primary culture origin used for in vitro testing and finally, monitoring for eventual genomic mutations due to prolonged cultivation or contact to biomaterials. Inconclusive results in just one of these aspects should lead to the disqualification of the monitored cultures from usage in vitro.
引用
收藏
页码:135 / 137
页数:3
相关论文
共 25 条
  • [21] Monitoring ZEO apoptotic potential in 2D and 3D cell cultures and associated spectroscopic evidence on mode of interaction with DNA
    Fahimeh Salehi
    Hossein Behboudi
    Gholamreza Kavoosi
    Sussan K. Ardestani
    Scientific Reports, 7
  • [22] Managing metastatic breast cancer via serial monitoring with circulating cell-free tumor DNA next generation sequencing testing
    Austin, Laura
    Nagy, Rebecca
    Zill, Oliver
    Lanman, Richard B.
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2016, 76
  • [23] New strategy to address DNA-methyl transferase activity in ovarian cancer cell cultures by monitoring the formation of 5-methylcytosine using HPLC-UV
    Iglesias Gonzalez, T.
    Blanco-Gonzalez, E.
    Montes-Bayon, M.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2016, 1028 : 16 - 24
  • [24] Utility of circulating tumor (ct)DNA testing for molecular residual disease (MRD) detection and treatment response monitoring in patients (pts) with renal cell carcinoma (RCC)
    Smigelski, M.
    Sudhaman, S.
    Nagpal, S.
    Brooks, B.
    Gerald, T.
    Sanchez-Mendez, R.
    Battista, C.
    Bhanvadia, R.
    Kazarian, A.
    Choi, S.
    Carson, C.
    Mahmood, T.
    White, E. Z.
    ElNaggar, A.
    Liu, M. C.
    Metcalf, M.
    Mckay, R. R.
    Corcoran, A.
    Margulis, V.
    Huang, W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1027 - S1027
  • [25] INVIVO CHEMOSENSITIVITY TESTING IN PATIENTS WITH GYNECOLOGIC MALIGNANCIES AND NUDE-MOUSE XENOGRAFTS BY MONITORING CELL KINETIC-PARAMETERS AND DNA DISTRIBUTION PATTERNS - A PRELIMINARY-REPORT
    SEVIN, BU
    POLLACK, A
    AVERETTE, HE
    RAMOS, R
    GREENING, SE
    EVANS, D
    GYNECOLOGIC ONCOLOGY, 1986, 24 (01) : 27 - 40